The aminoacyl-tRNA synthetases (aaRSs) comprise a family of up to twenty two enzymes that are essential to every living organism. Each enzyme recognizes a single cognate amino acid and covalently attaches it to the correct tRNA. The "charged" tRNA then transfers the amino acid at the ribosome for specific incorporation into the growing polypeptide chain. The fidelity of protein synthesis is completely dependent on accurate substrate recognition by the aaRSs, which guards against neurological disease. Some aaRSs have developed editing mechanisms to correct misactivated amino acids. These editing aaRSs clear the wrong amino acid by hydrolysis of either of two substrates-misactivated aminoacyl-adenylates ("pre-transfer" of amino acid to tRNA) or misacylated aa-tRNA ("post-transfer"). Although one of these mechanisms may dominate, most aaRSs that edit appear to operate by a mixture of pre-and post-transfer editing, which has historically complicated investigations to determine their respective molecular basis. New models for leucyl-tRNA synthetase (LeuRS) have been developed to isolate pre-transfer editing activities for detailed mechanistic investigations. In addition, pre-transfer editing can be dependent on tRNA. It is hypothesized that tRNA translocation between the synthetic and editing domains controls the enzyme's pathway choice between aminoacylation, post-transfer editing, and pre-transfer editing. This proposal outlines an interdisciplinary research plan that combines X-ray crystallography, computation, single molecule flourescence, biochemical, and molecular biology approaches to investigate tRNA translocation and the molecular basis of the enzyme- tRNA transition that forms stable aminoacylation and editing complexes. It will also characterize pre-transfer editing and its physiological impact on the cell. A detailed understanding of editing mechanisms will benefit ongoing pharmaceutical research that capitalizes upon aaRSs, especially the LeuRS editing site, as targets for antibiotic development. It will also enable re-engineering of aaRSs to activate alternate amino acids for incorporation into custom-designed proteins. These novel proteins could be used as therapeutics or tools in medicinal and technological applications.

Public Health Relevance

Decreases in the fidelity of protein synthesis due to editing defects in the tRNA synthetase can result in debilitating neurological disease. In addition, the editing site of leucyl-tRNA synthetase is the target for a truly new class of antibiotics with a novel mechanism of inhibition. These antibiotics can be effectively used to address the significant rise in antibiotic resistance that has threatened human health and welfare.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM063789-10
Application #
8287046
Study Section
Molecular Genetics A Study Section (MGA)
Program Officer
Bender, Michael T
Project Start
2001-09-01
Project End
2015-04-30
Budget Start
2012-05-01
Budget End
2013-04-30
Support Year
10
Fiscal Year
2012
Total Cost
$312,386
Indirect Cost
$107,386
Name
University of Illinois Urbana-Champaign
Department
Biochemistry
Type
Schools of Arts and Sciences
DUNS #
041544081
City
Champaign
State
IL
Country
United States
Zip Code
61820
Pang, Yan Ling Joy; Poruri, Kiranmai; Martinis, Susan A (2014) tRNA synthetase: tRNA aminoacylation and beyond. Wiley Interdiscip Rev RNA 5:461-80
Li, Li; Palencia, Andres; Lukk, Tiit et al. (2013) Leucyl-tRNA synthetase editing domain functions as a molecular rheostat to control codon ambiguity in Mycoplasma pathogens. Proc Natl Acad Sci U S A 110:3817-22
Li, Li; Martinis, Susan A; Luthey-Schulten, Zaida (2013) Capture and quality control mechanisms for adenosine-5'-triphosphate binding. J Am Chem Soc 135:6047-55
Sarkar, Jaya; Poruri, Kiranmai; Boniecki, Michal T et al. (2012) Yeast mitochondrial leucyl-tRNA synthetase CP1 domain has functionally diverged to accommodate RNA splicing at expense of hydrolytic editing. J Biol Chem 287:14772-81
Boniecki, Michal T; Martinis, Susan A (2012) Coordination of tRNA synthetase active sites for chemical fidelity. J Biol Chem 287:11285-9
Sarkar, Jaya; Martinis, Susan A (2011) Amino-acid-dependent shift in tRNA synthetase editing mechanisms. J Am Chem Soc 133:18510-3
Sarkar, Jaya; Mao, Weimin; Lincecum Jr, Tommie L et al. (2011) Characterization of benzoxaborole-based antifungal resistance mutations demonstrates that editing depends on electrostatic stabilization of the leucyl-tRNA synthetase editing cap. FEBS Lett 585:2986-91
Li, Li; Boniecki, Michal T; Jaffe, Jacob D et al. (2011) Naturally occurring aminoacyl-tRNA synthetases editing-domain mutations that cause mistranslation in Mycoplasma parasites. Proc Natl Acad Sci U S A 108:9378-83
Martinis, Susan A; Boniecki, Michal T (2010) The balance between pre- and post-transfer editing in tRNA synthetases. FEBS Lett 584:455-9
Hellmann, Rachel A; Martinis, Susan A (2009) Defects in transient tRNA translocation bypass tRNA synthetase quality control mechanisms. J Biol Chem 284:11478-84

Showing the most recent 10 out of 27 publications